+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06262321

Phase II Study of Thoracic Radiotherapy with Standard Systemic Therapy for Stage IV Non-Small Cell Lung Cancer at High Risk of Thoracic Symptom Progression

Led by University of Rochester · Updated on 2025-09-08

48

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a treatment approach for patients with stage IV metastatic non-small cell lung cancer NSCLC who have tumors in high-risk locations or of significant size within the chest. The study aims to investigate the use of prophylactic palliative thoracic radiotherapy alongside standard systemic therapies, such as chemotherapy and immunotherapy, to manage disease progression and symptoms. This is a Phase II, single-center, prospective trial focusing on improving symptom control in this patient population. Participants will receive standard systemic therapy as per usual care, with the addition of targeted radiotherapy directed at high-risk thoracic lesions including primary tumors, nodal metastases, and other metastases within the chest. Radiation treatment follows established palliative dosing guidelines without dose escalation. Other metastatic sites outside the thorax may be treated according to standard practice. The trial involves a single treatment group receiving prophylactic palliative radiotherapy. During the study, patients will be closely monitored for symptom progression in the irradiated thoracic areas at 6 months, 1 year, and 2 years. Researchers will assess outcomes such as freedom from local recurrence, overall survival, progression-free survival, and duration of maintenance therapy. Participants will undergo regular evaluations including imaging and clinical assessments to track treatment effects and safety. The study enrollment is open to adults aged 18 and older and is expected to continue until early 2029.

CONDITIONS

Brief Title

Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax

Research Team

T

Therese Smudzin

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here